Comment on Sun et al. SGLT2i Versus Metformin for Delirium Prevention in Type 2 Diabetes: A Real-World, Head-to-Head Comparative Study. Diabetes Care 2025;48:1361-1369
- PMID: 41719461
- DOI: 10.2337/dc25-1463
Comment on Sun et al. SGLT2i Versus Metformin for Delirium Prevention in Type 2 Diabetes: A Real-World, Head-to-Head Comparative Study. Diabetes Care 2025;48:1361-1369
Publication types
LinkOut - more resources
Full Text Sources
